Skip to main content
OpenTrials

Clinical trial condition

Non-Hodgkin Lymphoma

Explore clinical trials studying Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

214 public trials 63 recruiting studies
Refine in advanced search Browse all conditions

Non-Hodgkin Lymphoma trial results

Recruiting

A Study of GLB-002 in Patients With Relapsed or Refractory Non-Hodgkin Lymphomas

NCT06219356

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
  • Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China
View all 13 locations
View Trial Details
Recruiting

Methotrexate, Tafasitamab, Lenalidomide and Rituximab in Patients With PCNSL

NCT05583071

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Klinikum Stuttgart - Katharienenhospital Stuttgart, Baden-Wurttemberg, Germany
  • Universitätsklinikum Freiburg Freiburg im Breisgau, Baden-Würtemberg, Germany
  • University of Cologne Cologne, Germany
  • Universitätsklinikum Hamburg-Eppendorf Hamburg, Hamurg, Germany
View Trial Details
Recruiting

TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma

NCT06323525

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Biotherapeutic Department of Chinese PLA General Hospital Beijing, Beijing Municipality, China
  • Biotherapeutic Department of Chinese PLA General Hospital Beijing, China
  • School of Life Sciences, Peking University Beijing, China
View Trial Details

Related conditions